LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | BX-912 | 0.04 | uM | LJP5 | 1 | L24 | 72 | hr | 1389 | 4598 | 5772 | 0.7965 | 0.7904 |
| MCF7 | BX-912 | 0.04 | uM | LJP5 | 3 | L24 | 72 | hr | 1389 | 4892 | 6038 | 0.8101 | 0.8109 |
| MCF7 | BX-912 | 0.12 | uM | LJP5 | 1 | L23 | 72 | hr | 1389 | 5648 | 5772 | 0.9784 | 0.9789 |
| MCF7 | BX-912 | 0.12 | uM | LJP5 | 3 | L23 | 72 | hr | 1389 | 5321 | 6038 | 0.8812 | 0.8842 |
| MCF7 | BX-912 | 0.37 | uM | LJP5 | 1 | L22 | 72 | hr | 1389 | 4980 | 5772 | 0.8627 | 0.8613 |
| MCF7 | BX-912 | 0.37 | uM | LJP5 | 3 | L22 | 72 | hr | 1389 | 5552 | 6038 | 0.9194 | 0.9223 |
| MCF7 | BX-912 | 1.11 | uM | LJP5 | 1 | L21 | 72 | hr | 1389 | 3370 | 5772 | 0.5838 | 0.5392 |
| MCF7 | BX-912 | 1.11 | uM | LJP5 | 3 | L21 | 72 | hr | 1389 | 3769 | 6038 | 0.6242 | 0.6013 |
| MCF7 | BX-912 | 3.33 | uM | LJP5 | 1 | L20 | 72 | hr | 1389 | 2549 | 5772 | 0.4416 | 0.3437 |
| MCF7 | BX-912 | 3.33 | uM | LJP5 | 3 | L20 | 72 | hr | 1389 | 2726 | 6038 | 0.4514 | 0.3744 |
| MCF7 | BX-912 | 10 | uM | LJP5 | 1 | L19 | 72 | hr | 1389 | 1499 | 5772 | 0.2597 | 0.0378 |
| MCF7 | BX-912 | 10 | uM | LJP5 | 3 | L19 | 72 | hr | 1389 | 1572 | 6038 | 0.2603 | 0.0601 |
| MCF7 | Selumetinib | 0.04 | uM | LJP6 | 1 | M12 | 72 | hr | 1389 | 4832 | 5147 | 0.9388 | 0.9343 |
| MCF7 | Selumetinib | 0.04 | uM | LJP6 | 2 | M12 | 72 | hr | 1389 | 4788 | 5447 | 0.8789 | 0.8732 |
| MCF7 | Selumetinib | 0.04 | uM | LJP6 | 3 | M12 | 72 | hr | 1389 | 4986 | 5740 | 0.8686 | 0.8670 |
| MCF7 | Selumetinib | 0.12 | uM | LJP6 | 1 | M11 | 72 | hr | 1389 | 3803 | 5147 | 0.7389 | 0.7040 |
| MCF7 | Selumetinib | 0.12 | uM | LJP6 | 2 | M11 | 72 | hr | 1389 | 4102 | 5447 | 0.7530 | 0.7319 |
| MCF7 | Selumetinib | 0.12 | uM | LJP6 | 3 | M11 | 72 | hr | 1389 | 4478 | 5740 | 0.7801 | 0.7715 |
| MCF7 | Selumetinib | 0.37 | uM | LJP6 | 1 | M10 | 72 | hr | 1389 | 3340 | 5147 | 0.6489 | 0.5909 |
| MCF7 | Selumetinib | 0.37 | uM | LJP6 | 2 | M10 | 72 | hr | 1389 | 3263 | 5447 | 0.5989 | 0.5421 |
| MCF7 | Selumetinib | 0.37 | uM | LJP6 | 3 | M10 | 72 | hr | 1389 | 3282 | 5740 | 0.5717 | 0.5220 |
| MCF7 | Selumetinib | 1.11 | uM | LJP6 | 1 | M09 | 72 | hr | 1389 | 2965 | 5147 | 0.5761 | 0.4937 |
| MCF7 | Selumetinib | 1.11 | uM | LJP6 | 2 | M09 | 72 | hr | 1389 | 3172 | 5447 | 0.5822 | 0.5202 |
| MCF7 | Selumetinib | 1.11 | uM | LJP6 | 3 | M09 | 72 | hr | 1389 | 2875 | 5740 | 0.5008 | 0.4267 |
| MCF7 | Selumetinib | 3.33 | uM | LJP6 | 1 | M08 | 72 | hr | 1389 | 3058 | 5147 | 0.5941 | 0.5183 |